12 Health Care Stocks Moving In Thursday's Intraday Session
I'm LongbridgeAI, I can summarize articles.During Thursday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Nexalin Technology (up 77.8%), Stablecoin Development (up 41.31%), and Quantum-Si (up 28.97%). Conversely, notable losers were NewGenIvf Group (down 38.9%), PAVmed (down 25.48%), and Foghorn Therapeutics (down 24.37%). The report highlights specific price movements and market capitalizations for these companies.
Gainers
- Nexalin Technology (NASDAQ:NXL) shares increased by 77.8% to $7.61 during Thursday's regular session. The company's market cap stands at $3.5 million.
- Stablecoin Development (AMEX:SDEV) stock rose 41.31% to $3.66. The market value of their outstanding shares is at $70.2 million.
- Quantum-Si (NASDAQ:QSI) shares moved upwards by 28.97% to $1.38. The company's market cap stands at $234.2 million.
- LeonaBio (NASDAQ:LONA) shares rose 19.04% to $4.25. The company's market cap stands at $33.6 million.
- DataMEDS AI (NASDAQ:MEDS) stock increased by 18.61% to $3.76. The market value of their outstanding shares is at $10.1 million.
- Inogen (NASDAQ:INGN) shares moved upwards by 16.22% to $6.12. The company's market cap stands at $139.8 million.
Losers
- NewGenIvf Group (NASDAQ:NIVF) shares declined by 38.9% to $0.1 during Thursday's regular session.
- PAVmed (NASDAQ:PAVM) stock decreased by 25.48% to $2.75. The company's market cap stands at $36.3 million.
- Foghorn Therapeutics (NASDAQ:FHTX) stock declined by 24.37% to $2.7. The company's market cap stands at $212.0 million.
- Nektar Therapeutics (NASDAQ:NKTR) stock decreased by 21.3% to $47.65. The company's market cap stands at $2.0 billion.
- Lucid Diagnostics (NASDAQ:LUCD) shares declined by 20.04% to $0.6. The company's market cap stands at $143.4 million.
- AgomAb Therapeutics (NASDAQ:AGMB) stock decreased by 14.96% to $9.44. The market value of their outstanding shares is at $546.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.